Brian Martin
Overview
Explore the profile of Brian Martin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
670
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Headley S, Chapman D, Germain M, Evans E, Madsen K, Miele E, et al.
J Ren Nutr
. 2024 Oct;
PMID: 39362281
Objective: This study was designed to determine the effect of 16 weeks of supplementation with Hi-maize 260 resistant starch (RS) on the gut microbiota, uremic toxins (indoxyl sulfate and p-cresyl...
2.
Kriza C, Martin B, Bailey C, Bennett J
World J Surg Oncol
. 2024 Aug;
22(1):228.
PMID: 39215342
Introduction: Up to 88% of sentinel lymph node biopsies (SLNBs) are negative. The 31-gene expression profile (31-GEP) test can help identify patients with a low risk of SLN metastasis who...
3.
Romero G, Martin B, Gabris B, Salama G
Biochem Pharmacol
. 2024 Jul;
227:116407.
PMID: 38969298
Healthy aging results in cardiac structural and electrical remodeling that increase susceptibility to cardiovascular diseases. Relaxin has shown broad cardioprotective effects including anti-fibrotic, anti-arrhythmic and anti-inflammatory outcomes in multiple models....
4.
Chow J, Imani S, Kavisinghe I, Mittal R, Martin B
ANZ J Surg
. 2024 May;
94(7-8):1383-1390.
PMID: 38760999
Background: Diabetic foot ulcers (DFUs) are a challenging complication of diabetes mellitus, often leading to poor clinical outcomes and significant socioeconomic burdens. We evaluated the effectiveness of a definitive single-stage...
5.
Prieto P, Goldberg M, Martin B
J Am Acad Dermatol
. 2024 May;
91(3):e73-e74.
PMID: 38734239
No abstract available.
6.
Block R, Patterson D, Siegel J, Martin B, Quick A, Hunt J
J Adv Pract Oncol
. 2024 Jan;
14(7):586-596.
PMID: 38196667
Objective: The 31-gene expression profile (31-GEP) can predict the risk of recurrence and metastasis in cutaneous melanoma (CM). We assessed the viewpoints and use of 31-GEP testing by physician assistants...
7.
Prieto P, Goldberg M, Martin B
Ann Surg Oncol
. 2023 Jul;
30(11):6357-6358.
PMID: 37400617
No abstract available.
8.
Jay R, Witkoff B, Ivanov N, Kirk S, McBride M, Martin B, et al.
J Drugs Dermatol
. 2023 May;
22(5):451-456.
PMID: 37133469
Understanding the metastatic potential of a skin cancer is essential to effective management. Gene expression profiling (GEP) is an innovative technology that has allowed for a better understanding of tumor...
9.
Yamamoto M, Sickle-Santanello B, Beard T, Essner R, Martin B, Bailey C, et al.
Curr Med Res Opin
. 2023 Jan;
39(3):417-423.
PMID: 36617959
Background: The 31-gene expression profile test (Class 1A: low-risk; 1B/2A: intermediate-risk; 2B: high-risk) is validated to identify patients with cutaneous melanoma who can safely forego sentinel lymph node biopsy (SLNB)....
10.
Sheth B, Schnabel S, Comber B, Martin B, McGowan M, Bartley G
Am J Ophthalmol
. 2022 Nov;
247:1-8.
PMID: 36370838
Purpose: To evaluate the likelihood of disciplinary actions against medical licenses of ophthalmologists who maintained board certification through successful completion of the American Board of Ophthalmology Maintenance of Certification program...